Retiform purpura-like lesions are rarely seen clinically and can be induced by cutaneous vascular wall damage or a lumen-occlusive disease arising from a broad range of triggers, including infection, drugs, emboli, cryoglobulinemia, disseminated intravascular coagulation, and autoimmune disease. Here, we present the case of a patient suffering from both systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), with retiform purpura as the first lesion and lacking other typical symptoms of SLE, such as photosensitivity, malar rash, ulceration of the mouth and nose, alopecia, and joint pain.
PetriMOrbaiAMAlarcónGS, et al.Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum2012; 64(8): 2677–2686.
2.
MiyakisSLockshinMDAtsumiT, et al.International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost2006; 4(2): 295–306.
3.
BazzanMVaccarinoAMarlettoF. Systemic lupus erythematosus and thrombosis. Thromb J2015; 13: 16.
4.
SammaritanoLR. Antiphospholipid syndrome. Best Pract Res Clin Rheumatol2020; 34(1): 101463.
5.
GeorgesenCFoxLPHarpJ. Retiform purpura: a diagnostic approach. J Am Acad Dermatol2020; 82(4): 783–796.
6.
Carmona-RochaEIznardoHPuigL. Retiform purpura in an 80-year-old woman. Int J Dermatol2022; 61(10): 1225–1226.
Miri-AliabadG. Retiform purpura with overlying bullae: unusual presentation of systemic lupus erythematous in children. Turk Arch Pediatr2021; 56(4): 403–404.
9.
GrinnellMBathADiMaioD, et al.Retiform non-blanchable purpuric plaques in a patient with systemic lupus erythematosus. Lupus2019; 28(8): 1013–1016.
10.
WysongAVenkatesanP. An approach to the patient with retiform purpura. Dermatol Ther2011; 24(2): 151–172.
11.
JonesAWallingHJonesA. Retiform purpura in plaques: a morphological approach to diagnosis. Clin Exp Dermatol2007; 32(5): 596–602.
